... These include phosphodiesterase type 5 inhibitors (PDE5 inhibitors) such as sildenafil (Revatio) and tadalafil (Adcirca, Alyq).Other medications called soluble guanylate cyclase stimulators, such as riociguat (Adempas), work slightly differently, though they also aim to increase nitric oxide levels and widen pulmonary blood vessels.Doctors do not usually ...
4 PAH Pathways Explained: How Treatments Target Them
... These include phosphodiesterase type 5 inhibitors (PDE5 inhibitors) such as sildenafil (Revatio) and tadalafil (Adcirca, Alyq).Other medications called soluble guanylate cyclase stimulators, such as riociguat (Adempas), work slightly differently, though they also aim to increase nitric oxide levels and widen pulmonary blood vessels.Doctors do not usually ...
... In people with PAH, ERAs can help slow disease progression and may even improve heart and lung function.Phosphodiesterase-5 InhibitorsTadalafil (Adcirca, Tadliq, Alyq) and sildenafil (Revatio, Liqrev) are phosphodiesterase-5 (PDE5) inhibitors. ...
5 Pulmonary Hypertension Medications and Treatment Options
... In people with PAH, ERAs can help slow disease progression and may even improve heart and lung function.Phosphodiesterase-5 InhibitorsTadalafil (Adcirca, Tadliq, Alyq) and sildenafil (Revatio, Liqrev) are phosphodiesterase-5 (PDE5) inhibitors. ...